Raysum Co., Ltd. (TYO:8890)
5,890.00
0.00 (0.00%)
Inactive · Last trade price
on Mar 3, 2025
Raysum Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
Revenue | 96,868 | 94,265 | 67,906 | 68,402 | 32,219 | 54,938 | Upgrade
|
Revenue Growth (YoY) | -0.95% | 38.82% | -0.73% | 112.30% | -41.35% | -6.16% | Upgrade
|
Cost of Revenue | 71,837 | 64,535 | 47,538 | 51,958 | 25,979 | 38,190 | Upgrade
|
Gross Profit | 25,031 | 29,730 | 20,368 | 16,444 | 6,240 | 16,748 | Upgrade
|
Selling, General & Admin | 7,426 | 6,109 | 5,029 | 5,080 | 4,398 | 4,504 | Upgrade
|
Other Operating Expenses | 797 | 797 | 967 | - | - | - | Upgrade
|
Operating Expenses | 8,325 | 7,144 | 7,154 | 5,684 | 4,595 | 4,504 | Upgrade
|
Operating Income | 16,706 | 22,586 | 13,214 | 10,760 | 1,645 | 12,244 | Upgrade
|
Interest Expense | -1,120 | -594 | -456 | -523 | -399 | -285 | Upgrade
|
Interest & Investment Income | 54 | 33 | 11 | 43 | 31 | 22 | Upgrade
|
Currency Exchange Gain (Loss) | 263 | 263 | 138 | 150 | 45 | -13 | Upgrade
|
Other Non Operating Income (Expenses) | -457 | -409 | -57 | 15 | 29 | -6 | Upgrade
|
EBT Excluding Unusual Items | 15,446 | 21,879 | 12,850 | 10,445 | 1,351 | 11,962 | Upgrade
|
Gain (Loss) on Sale of Investments | -194 | -115 | 14 | 17 | -47 | -52 | Upgrade
|
Gain (Loss) on Sale of Assets | 2 | - | - | -30 | - | - | Upgrade
|
Asset Writedown | -1,588 | -1,538 | -28 | -29 | -73 | -27 | Upgrade
|
Other Unusual Items | -3,052 | -2,928 | -243 | 1 | 3 | 117 | Upgrade
|
Pretax Income | 10,614 | 17,298 | 12,593 | 10,404 | 1,234 | 12,000 | Upgrade
|
Income Tax Expense | 2,688 | 5,780 | 4,201 | 3,777 | 571 | 4,061 | Upgrade
|
Earnings From Continuing Operations | 7,926 | 11,518 | 8,392 | 6,627 | 663 | 7,939 | Upgrade
|
Minority Interest in Earnings | -10 | -5 | -16 | 3 | - | - | Upgrade
|
Net Income | 7,916 | 11,513 | 8,376 | 6,630 | 663 | 7,939 | Upgrade
|
Net Income to Common | 7,916 | 11,513 | 8,376 | 6,630 | 663 | 7,939 | Upgrade
|
Net Income Growth | -41.58% | 37.45% | 26.33% | 900.00% | -91.65% | 0.57% | Upgrade
|
Shares Outstanding (Basic) | 29 | 28 | 31 | 37 | 37 | 38 | Upgrade
|
Shares Outstanding (Diluted) | 29 | 28 | 31 | 37 | 37 | 38 | Upgrade
|
Shares Change (YoY) | 1.41% | -8.75% | -15.24% | 0.03% | -4.09% | -9.01% | Upgrade
|
EPS (Basic) | 275.60 | 406.28 | 269.71 | 180.96 | 18.10 | 207.88 | Upgrade
|
EPS (Diluted) | 275.60 | 406.28 | 269.71 | 180.96 | 18.10 | 207.88 | Upgrade
|
EPS Growth | -42.39% | 50.64% | 49.04% | 899.71% | -91.29% | 10.52% | Upgrade
|
Free Cash Flow | -41,917 | 934 | 8,107 | 13,147 | -21,249 | 2,594 | Upgrade
|
Free Cash Flow Per Share | -1459.38 | 32.96 | 261.05 | 358.84 | -580.15 | 67.92 | Upgrade
|
Dividend Per Share | 175.000 | 175.000 | 55.000 | 37.000 | 4.000 | 45.000 | Upgrade
|
Dividend Growth | 218.18% | 218.18% | 48.65% | 825.00% | -91.11% | 0% | Upgrade
|
Gross Margin | 25.84% | 31.54% | 29.99% | 24.04% | 19.37% | 30.49% | Upgrade
|
Operating Margin | 17.25% | 23.96% | 19.46% | 15.73% | 5.11% | 22.29% | Upgrade
|
Profit Margin | 8.17% | 12.21% | 12.33% | 9.69% | 2.06% | 14.45% | Upgrade
|
Free Cash Flow Margin | -43.27% | 0.99% | 11.94% | 19.22% | -65.95% | 4.72% | Upgrade
|
EBITDA | 17,244 | 23,077 | 13,782 | 12,407 | 2,383 | 12,632 | Upgrade
|
EBITDA Margin | 17.80% | 24.48% | 20.30% | 18.14% | 7.40% | 22.99% | Upgrade
|
D&A For EBITDA | 538 | 491 | 568 | 1,647 | 738 | 388 | Upgrade
|
EBIT | 16,706 | 22,586 | 13,214 | 10,760 | 1,645 | 12,244 | Upgrade
|
EBIT Margin | 17.25% | 23.96% | 19.46% | 15.73% | 5.11% | 22.29% | Upgrade
|
Effective Tax Rate | 25.32% | 33.41% | 33.36% | 36.30% | 46.27% | 33.84% | Upgrade
|
Advertising Expenses | - | 658 | 445 | 507 | 318 | 334 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.